| Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors M Mammen, SK Choi, GM Whitesides Angewandte Chemie International Edition 37 (20), 2754-2794, 1998 | 5123 | 1998 |
| Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren M Mammen, SK Choi, GM Whitesides Angewandte Chemie 110 (20), 2908-2953, 1998 | 556 | 1998 |
| Mechanisms of drug release in nanotherapeutic delivery systems PT Wong, SK Choi Chemical reviews 115 (9), 3388-3432, 2015 | 486 | 2015 |
| Generation and in situ evaluation of libraries of poly (acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination SK Choi, M Mammen, GM Whitesides Journal of the American Chemical Society 119 (18), 4103-4111, 1997 | 286 | 1997 |
| Synthetic multivalent molecules: concepts and biomedical applications S Choi John Wiley & Sons, 2004 | 261 | 2004 |
| Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate SK Choi, T Thomas, MH Li, A Kotlyar, A Desai, JR Baker Jr Chemical communications 46 (15), 2632-2634, 2010 | 169 | 2010 |
| Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic TP Thomas, B Huang, SK Choi, JE Silpe, A Kotlyar, AM Desai, H Zong, ... Molecular pharmaceutics 9 (9), 2669-2676, 2012 | 151 | 2012 |
| Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface SK Choi, A Myc, JE Silpe, M Sumit, PT Wong, K McCarthy, AM Desai, ... ACS nano 7 (1), 214-228, 2013 | 145 | 2013 |
| Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. PT Brackley, DR Bell, SK Choi, K Nakanishi, PN Usherwood Journal of Pharmacology and Experimental Therapeutics 266 (3), 1573-1580, 1993 | 127 | 1993 |
| Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups SK Choi, M Mammen, GM Whitesides Chemistry & biology 3 (2), 97-104, 1996 | 119 | 1996 |
| Yolk-structured multifunctional up-conversion nanoparticles for synergistic photodynamic–sonodynamic antibacterial resistance therapy F Xu, M Hu, C Liu, SK Choi Biomaterials science 5 (4), 678-685, 2017 | 104 | 2017 |
| Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery PT Wong, SK Choi International journal of molecular sciences 16 (1), 1772-1790, 2015 | 101 | 2015 |
| Optically controlled collisions of biological objects to evaluate potent polyvalent inhibitors of virus-cell adhesion M Mammen, K Helmerson, R Kishore, SK Choi, WD Phillips, ... Chemistry & biology 3 (9), 757-763, 1996 | 96 | 1996 |
| Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery TP Thomas, SK Choi, MH Li, A Kotlyar, JR Baker Jr Bioorganic & medicinal chemistry letters 20 (17), 5191-5194, 2010 | 95 | 2010 |
| A photochemical approach for controlled drug release in targeted drug delivery SK Choi, M Verma, J Silpe, RE Moody, K Tang, JJ Hanson, JR Baker Jr Bioorganic & medicinal chemistry 20 (3), 1281-1290, 2012 | 92 | 2012 |
| Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting MH Li, SK Choi, TP Thomas, A Desai, KH Lee, A Kotlyar, MMB Holl, ... European journal of medicinal chemistry 47, 560-572, 2012 | 92 | 2012 |
| Dual-acting antihypertensive agents P Allegretti, SK Choi, R Gendron, PR Fatheree, K Jendza, RM McKinnell, ... US Patent 8,013,005, 2011 | 80 | 2011 |
| β2-adrenergic receptor agonists EJ Moran, SK Choi US Patent 6,541,669, 2003 | 79 | 2003 |
| β2-adrenergic receptor agonists EJ Moran, JH Griffin, SK Choi US Patent 6,576,793, 2003 | 77 | 2003 |
| β2-adrenergic receptor agonists EJ Moran, JH Griffin, SK Choi US Patent 6,576,793, 2003 | 77 | 2003 |
